You can buy or sell VIRI and other stocks, options, and ETFs commission-free!
Virios Therapeutics, Inc. Common Stock, also called Virios Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1 a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA. The listed name for VIRI is Virios Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 19, Pre-Market